In the present manuscript we demonstrate that AR42 and sodium valproate, in multiple tumor types, reduce the expression of PD-L1, PD-L2 and ornithine decarboxylase (ODC) and increase the expression of the class I MHC molecule MHCA. The gene discussed is PDCD1LG2; the disease is neoplasm.